Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Adolescent
Adult
Age Factors
Aged
Angiotensin-Converting Enzyme 2
/ genetics
Asthma
/ epidemiology
Basigin
/ genetics
COVID-19
/ epidemiology
Child
Child, Preschool
Chronic Disease
/ epidemiology
Comorbidity
Dipeptidyl Peptidase 4
/ genetics
Female
Gene Expression
/ genetics
Humans
Hypertension
/ epidemiology
Immunity, Innate
/ immunology
Infant
Male
Middle Aged
Obesity
/ epidemiology
Pulmonary Disease, Chronic Obstructive
/ epidemiology
Risk Factors
SARS-CoV-2
/ genetics
Young Adult
COPD
COVID-19
COVID-19 children
SARS receptor
asthma
hypertension
obesity
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
13
05
2020
revised:
20
05
2020
accepted:
25
05
2020
pubmed:
5
6
2020
medline:
15
12
2020
entrez:
5
6
2020
Statut:
ppublish
Résumé
Morbidity and mortality from COVID-19 caused by novel coronavirus SARS-CoV-2 is accelerating worldwide, and novel clinical presentations of COVID-19 are often reported. The range of human cells and tissues targeted by SARS-CoV-2, its potential receptors and associated regulating factors are still largely unknown. The aim of our study was to analyze the expression of known and potential SARS-CoV-2 receptors and related molecules in the extensive collection of primary human cells and tissues from healthy subjects of different age and from patients with risk factors and known comorbidities of COVID-19. We performed RNA sequencing and explored available RNA-Seq databases to study gene expression and co-expression of ACE2, CD147 (BSG), and CD26 (DPP4) and their direct and indirect molecular partners in primary human bronchial epithelial cells, bronchial and skin biopsies, bronchoalveolar lavage fluid, whole blood, peripheral blood mononuclear cells (PBMCs), monocytes, neutrophils, DCs, NK cells, ILC1, ILC2, ILC3, CD4 ACE2 and TMPRSS2 were coexpressed at the epithelial sites of the lung and skin, whereas CD147 (BSG), cyclophilins (PPIA andPPIB), CD26 (DPP4), and related molecules were expressed in both epithelium and in immune cells. We also observed a distinct age-related expression profile of these genes in the PBMCs and T cells from healthy children and adults. Asthma, COPD, hypertension, smoking, obesity, and male gender status generally led to the higher expression of ACE2- and CD147-related genes in the bronchial biopsy, BAL, or blood. Additionally, CD147-related genes correlated positively with age and BMI. Interestingly, we also observed higher expression of CD147-related genes in the lesional skin of patients with atopic dermatitis. Our data suggest different receptor repertoire potentially involved in the SARS-CoV-2 infection at the epithelial barriers and in the immune cells. Altered expression of these receptors related to age, gender, obesity and smoking, as well as with the disease status, might contribute to COVID-19 morbidity and severity patterns.
Sections du résumé
BACKGROUND
Morbidity and mortality from COVID-19 caused by novel coronavirus SARS-CoV-2 is accelerating worldwide, and novel clinical presentations of COVID-19 are often reported. The range of human cells and tissues targeted by SARS-CoV-2, its potential receptors and associated regulating factors are still largely unknown. The aim of our study was to analyze the expression of known and potential SARS-CoV-2 receptors and related molecules in the extensive collection of primary human cells and tissues from healthy subjects of different age and from patients with risk factors and known comorbidities of COVID-19.
METHODS
We performed RNA sequencing and explored available RNA-Seq databases to study gene expression and co-expression of ACE2, CD147 (BSG), and CD26 (DPP4) and their direct and indirect molecular partners in primary human bronchial epithelial cells, bronchial and skin biopsies, bronchoalveolar lavage fluid, whole blood, peripheral blood mononuclear cells (PBMCs), monocytes, neutrophils, DCs, NK cells, ILC1, ILC2, ILC3, CD4
RESULTS
ACE2 and TMPRSS2 were coexpressed at the epithelial sites of the lung and skin, whereas CD147 (BSG), cyclophilins (PPIA andPPIB), CD26 (DPP4), and related molecules were expressed in both epithelium and in immune cells. We also observed a distinct age-related expression profile of these genes in the PBMCs and T cells from healthy children and adults. Asthma, COPD, hypertension, smoking, obesity, and male gender status generally led to the higher expression of ACE2- and CD147-related genes in the bronchial biopsy, BAL, or blood. Additionally, CD147-related genes correlated positively with age and BMI. Interestingly, we also observed higher expression of CD147-related genes in the lesional skin of patients with atopic dermatitis.
CONCLUSIONS
Our data suggest different receptor repertoire potentially involved in the SARS-CoV-2 infection at the epithelial barriers and in the immune cells. Altered expression of these receptors related to age, gender, obesity and smoking, as well as with the disease status, might contribute to COVID-19 morbidity and severity patterns.
Identifiants
pubmed: 32496587
doi: 10.1111/all.14429
pmc: PMC7300910
doi:
Substances chimiques
BSG protein, human
0
Basigin
136894-56-9
DPP4 protein, human
EC 3.4.14.5
Dipeptidyl Peptidase 4
EC 3.4.14.5
ACE2 protein, human
EC 3.4.17.23
Angiotensin-Converting Enzyme 2
EC 3.4.17.23
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2829-2845Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Infect Dis. 2005 Mar 1;191(5):755-60
pubmed: 15688292
Biochem Biophys Res Commun. 2007 Nov 23;363(3):495-9
pubmed: 17888876
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e241-e242
pubmed: 32223003
Cancer Res. 2009 Feb 15;69(4):1293-301
pubmed: 19176383
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Leukoc Biol. 2015 Jul;98(1):33-48
pubmed: 25977287
Emerg Microbes Infect. 2020 Dec;9(1):155-168
pubmed: 31964246
J Virol. 2014 Aug;88(16):9220-32
pubmed: 24899185
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213
pubmed: 32215952
Am J Physiol Cell Physiol. 2010 Nov;299(5):C1212-9
pubmed: 20810913
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452
pubmed: 32339344
Mol Immunol. 2008 Mar;45(6):1703-11
pubmed: 17996943
J Exp Med. 2005 Aug 1;202(3):415-24
pubmed: 16043521
Virol J. 2017 Jun 15;14(1):114
pubmed: 28619100
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
J Microbiol Biotechnol. 2020 Mar 28;30(3):427-438
pubmed: 31838832
J Biol Chem. 2008 Feb 29;283(9):5554-66
pubmed: 18160397
Cell. 2015 May 7;161(4):817-32
pubmed: 25957687
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
Sci Rep. 2017 Jun 14;7(1):3501
pubmed: 28615725
J Exp Med. 2011 Jul 4;208(7):1459-71
pubmed: 21708929
Blood. 2011 Nov 10;118(19):5141-51
pubmed: 21937704
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Trends Mol Med. 2001 May;7(5):213-21
pubmed: 11325633
J Virol. 2010 May;84(9):4183-93
pubmed: 20147391
Nat Commun. 2015 Oct 22;6:8570
pubmed: 26490707
Allergy. 2020 Nov;75(11):2829-2845
pubmed: 32496587
Diabetes Metab Res Rev. 2020 Apr 21;:e3325
pubmed: 32314503
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6360-5
pubmed: 11353871
Biochem J. 2013 Jan 15;449(2):437-48
pubmed: 23005037
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
Mol Cell Proteomics. 2005 Aug;4(8):1061-71
pubmed: 15901826
J Gen Virol. 2011 Nov;92(Pt 11):2542-2548
pubmed: 21752960
Viruses. 2013 May 22;5(5):1250-60
pubmed: 23698397
J Cell Sci. 2008 Feb 15;121(Pt 4):487-95
pubmed: 18256385
EMBO J. 2000 Aug 1;19(15):3896-904
pubmed: 10921872
Allergy. 2020 Jul;75(7):1564-1581
pubmed: 32396996
J Pediatr. 1992 Feb;120(2 Pt 1):216-22
pubmed: 1735817
Front Endocrinol (Lausanne). 2017 Dec 22;8:360
pubmed: 29312150
J Biochem. 2016 May;159(5):481-90
pubmed: 26684586
IUBMB Life. 2012 Jan;64(1):1-9
pubmed: 22131303
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
Emerg Microbes Infect. 2020 Dec;9(1):601-604
pubmed: 32178593
J Am Soc Nephrol. 2009 Jul;20(7):1565-76
pubmed: 19443639
Cell Host Microbe. 2020 Mar 11;27(3):325-328
pubmed: 32035028
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Biochem Biophys Res Commun. 1994 Sep 15;203(2):1224-9
pubmed: 7522442
J Infect Dis. 2016 Mar 15;213(6):904-14
pubmed: 26203058
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7499-504
pubmed: 15890777
Cancer Res. 2013 Jan 1;73(1):172-83
pubmed: 23135911
Thromb Haemost. 2009 Apr;101(4):682-6
pubmed: 19350111
J Biol Chem. 1997 Nov 14;272(46):29174-80
pubmed: 9360995
J Med Virol. 2020 Sep;92(9):1676-1680
pubmed: 32330305
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
J Immunol. 2005 Jul 1;175(1):591-8
pubmed: 15972696
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
PLoS Pathog. 2011 Oct;7(10):e1002331
pubmed: 22046132
Blood. 2018 Mar 8;131(10):1111-1121
pubmed: 29352039
Clin Exp Immunol. 2010 Jun;160(3):305-17
pubmed: 20345978
J Virol. 2007 Nov;81(21):11620-33
pubmed: 17715225
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3
pubmed: 32333915
J Eur Acad Dermatol Venereol. 2020 May;34(5):1074-1079
pubmed: 31733162
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
PLoS One. 2013 Jul 29;8(7):e70011
pubmed: 23922889
IUBMB Life. 2009 Jun;61(6):591-9
pubmed: 19472175
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Nat Rev Immunol. 2010 Sep;10(9):645-56
pubmed: 20725108
Nat Rev Immunol. 2005 Jun;5(6):472-84
pubmed: 15928679
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Int J Biol Sci. 2013 Dec 13;10(1):43-52
pubmed: 24391450